By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Avineuro 

6605 Nancy Ridge Drive
Suite 126
San Diego  California  92121  U.S.A.
Phone: 858-436-1537 Fax: 858-228-9798


SEARCH JOBS


Industry
Pharmaceutical






Company News
Avineuro Announces Beginning of Phase 2b Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia 7/15/2013 10:12:03 AM
Avineuro Reports Positive Phase 2a Clinical Proof of Concept Trial Results on AVN-211, Potent Small Molecule for Treatment of Schizophrenia 2/22/2011 9:09:44 AM
Avineuro Reports Positive Phase I Clinical Trial Results On AVN-322, Potent Small Molecule For Treatment Of Alzheimer’s Disease 3/1/2010 11:48:34 AM
Avineuro Announces Beginning Of Phase II Clinical Studies Of AVN-101, Potent Small Molecule For Treatment Of Alzheimer's Disease And Anxiety 2/2/2010 12:11:24 PM
Avineuro Reports Positive Phase I Clinical Trial Results on AVN-101, Potent Small Molecule for Treatment of Alzheimer’s Disease 10/27/2009 12:20:35 PM
Clinical Development Milestones Achieved for Avineuro CNS Collaboration with ChemDiv, Inc. 9/16/2009 11:02:16 AM
Avineuro Announces Beginning Of Phase II Clinical Studies Of AVN-397, Potent Small Molecule For Treatment Of Anxiety And Alzheimer's Disease 6/23/2009 11:50:25 AM
Avineuro Announces Beginning Of Phase I Clinical Studies Of AVN-322, Potent Small Molecule For Treatment Of Alzheimer's Disease 6/16/2009 11:48:07 AM
Avineuro Announces Beginning Of Phase II Clinical Studies Of AVN-211, Potent Small Molecule For Treatment Of Schizophrenia 6/10/2009 8:18:26 AM
Avineuro Reports Positive Phase I Clinical Trial Results On AVN-211, Potent Small Molecule For Treatment Of Schizophrenia 5/19/2009 1:30:24 PM
12
//-->